Nonischemic dilated cardiomyopathy (DCM) often has a genetic pathogenesis. Because of
the large number of genes and alleles attributed to DCM, comprehensive genetic testing …

Cardiomyopathies (ie, diseases of the heart muscle) are major causes of morbidity and
mortality. A significant percentage of patients with cardiomyopathies have genetic-based …

Familial dilated cardiomyopathy (DCM) is a heterogeneous disease; although 30 disease
genes have been discovered, they explain only no more than half of all cases; in addition …

Dilated cardiomyopathy (DCM) represents the final common morphofunctional pathway of
various pathological conditions in which a combination of myocyte injury and necrosis …

Introduction: Dilated cardiomyopathy (DCM) is the most common cardiomyopathy and
occurs often in families. As an inherited disease, understanding the significance of …

Purpose To assess the relative cost-effectiveness of cascade genetic testing in
asymptomatic relatives of patients with dilated cardiomyopathy (DCM) compared with …

Background: The clinical outcome of patients affected by dilated cardiomyopathy (DCM) is
heterogeneous, since its pathophysiology is only partially understood. Interleukin 1β levels …

Coenzyme Q (CoQ) is an essential lipid of cells present in all cellular compartments. The
functions of CoQ in mitochondrial respiration and as an antioxidant are established …

Background Dilated cardiomyopathy (DCM) is characterized by idiopathic dilation and
systolic contractile dysfunction of the cardiac chambers. The present work aimed to study the …

Sudden death is one of the most common causes of death in humans in Western countries.
Approximately 85% of these cases are of cardiac origin. In dogs and cats, sudden cardiac …